Begin main content

Icatibant

Last Updated: March 4, 2014
Result type: Reports
Project Number: SR0375-000
Product Line: Common Drug Review

Generic Name: Icatibant

Brand Name: Firazyr

Manufacturer: Shire Human Genetic Therapies (Canada) Inc.

Indications: Angioedema, hereditary

Submission Type: Pre-NOC

Project Status: Active

Date Recommendation Issued: December 19, 2014

Recommendation Type: List with clinical criteria and/or conditions

Tags

angioedemas, hereditary, other miscellaneous topics